Podcasts about clinical research unit

Thank you for joining us for another episode of the Low Carb MD Podcast. Dr. Mariela Glandt, a Harvard and Columbia-educated endocrinologist, has extensive experience in treating diabetes. She is the founder and director of Glandt Center for Diabetes Care, which uses the ketogenic diet as its main therapeutic tool. Dr. Glandt has worked in New York, both in a private clinic and at Mount Sinai Hospital. In Israel, she worked as the director of the Clinical Research Unit for Diabetes at Hadassah Ein Kerem University Medical Center. Dr. Glandt publishes articles in international journals, is involved in clinical trials, and continues to mentor interns at Bronx Hospital in New York. She is a co-founder of Eatsane, which produces low-carb food with no artificial sweeteners. In addition, she is a co-founder of Metabolix, a non-profit organization that aims to educate people to help them achieve optimal metabolic health. In this episode, Dr. Brian, Dr. Tro, and Dr. Mariela talk about… The power of lifestyle intervention for metabolic health The concept of food/nutrition elitism and wether there is any merit to the idea that we shouldn't tell poor people to eat real food How to reach the hardest to reach communities with nutritional education The merits and disadvantages of various models of healthcare Battling food addiction Fixing the standard medical care model For more information, please see the links below. Thank you for listening!   Links:   Please consider supporting us on Patreon: https://www.lowcarbmd.com/   Dr. Mariela Glandt: Glandt Center for Diabetes Care: https://www.glandt.co.il/en/home Eatsane: https://eatsane.com Metabolix: https://www.glandt.co.il/en/resources   Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author   Dr. Tro Kalayjian:  Website: https://www.doctortro.com/ Twitter: https://twitter.com/DoctorTro Instagram: https://www.instagram.com/doctortro/   Additional Links: For Better, For Poorer: Low-Carb Diets Work for All Incomes (Article by Nina Teicholz): https://www.medscape.com/viewarticle/richer-poorer-low-carb-diets-work-all-incomes-2024a1000cw5 Journal of Metabolic Health article by Dr. Mariela: https://journalofmetabolichealth.org/index.php/jmh/article/view/87 The Metabolic Revolution: https://www.metabolicrevolution.org   Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.    Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://doctortro.com/community/ 

Dr. Sher Bahadur Pun, a renowned epidemiologist, specializes in general medicine and infectious diseases. He leads the Clinical Research Unit at Sukraraj Tropical and Infectious Disease Hospital in Teku. A graduate of St. Petersburg State Pediatric Medical Academy in Russia, Dr. Pun is a key figure in Nepal's public health and epidemiology. Join us in this episode as Dr. Sher Bahadur Pun discusses the outbreaks of Monkeypox, dengue, chikungunya, and COVID-19, and shares vital prevention strategies. He also explores the issue of contaminated jar water, highlighting its role in the spread of diseases.

Kaniksha Desai and Skand Shekhar discuss the interconnectedness between sleep and thyroid, including hypothyroidism and hyperthyroidism. This podcast is intended for healthcare professionals only. Kaniksha Desai, MD, Associate Professor, Quality Director, Department of Endocrinology, Stanford University School of Medicine, Palo Alto, California Skand Shekhar, MD, MHS, Principal Investigator, Medical Director, National Institute of Environmental Health Sciences, National Institutes of Health; Medical Director, Clinical Research Unit, Tertiary Care Center, Research Triangle Park, North Carolina

Welcome to Protecting Your Nest with Dr. Tony Hampton. Dr. Mariela Glandt, a Harvard and Columbia-educated endocrinologist, has extensive experience in treating diabetes. She is the founder and director of Glandt Center for Diabetes Care, which uses the ketogenic diet as its main therapeutic tool. Dr. Glandt has worked in New York, both in a private clinic and at Mount Sinai Hospital. In Israel, she worked as the director of the Clinical Research Unit for Diabetes at Hadassah Ein Kerem University Medical Center.  Dr. Glandt publishes articles in international journals, is involved in clinical trials, and continues to mentor interns at Bronx Hospital in New York. She is a co-founder of Eatsane, which produces low-carb food with no artificial sweeteners. In addition, she is a co-founder of Metabolix, a non-profit organization that aims to educate people to help them achieve optimal metabolic health. In this discussion, Drs. Tony and Mariela talk about: (04:27) Israel—it's culture and food (12:20) Dr. Mariela's career path and the development of  her interest in the ketogenic/low-carb diet (17:05) Why insulin is not the answer for Type 2 diabetes (27:02) How to get a Type 2 patient off of insulin safely and productively (31:31) The SGLT category of medications (37:45) How to meet people where they are at in order to help them succeed on a low-carb diet (42:55) How to get specialists and doctors interested and educated about low-carb and metabolic health (47:41) Dietary guidelines in Israel (48:08) The incredible benefits of the carnivore diet Thank you for listening to Protecting Your Nest. For additional resources and information, please see the links below.   Links:   Dr. Mariela Glandt: The Glandt Center for Diabetes Care Twitter Instagram OWNA Health   Dr. Tony Hampton: Linktree Instagram Account LinkedIn Account Ritmos Negros Podcast Q Med Symposium for Metabolic Health Lectures How Waking Up Every Day at 4:30 Can Change Your Life

Welcome to this special episode of the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. For major FDA decisions in the field of neurology, we release short special episodes to offer a snapshot of the news, including the main takeaways for the clinical community, as well as highlights of the efficacy and safety profile of the agent in question. In this episode, we're covering the recent approval of tofersen (Qalsody; Biogen/Ionis) in SOD1 mutation-mediated amyotrophic lateral sclerosis (ALS). Offering commentary is Angela Genge, MD, FRCPC, the director of the ALS Centre of Excellence for Research and Patient Care at McGill University, and an executive at the Clinical Research Unit at The Neuro (Montreal Neurological Institute-Hospital). Tofersen is an antisense oligonucleotide, and its new drug application (NDA) was supported by data from a phase 1 study of healthy volunteers, a phase 1/2 dose-ascending study, the pivotal phase 3 VALOR study (NCT02623699), and its open-label extension. For more of NeurologyLive®'s coverage of tofersen's approval, head here: FDA Approves Tofersen as First SOD1-ALS Treatment Episode Breakdown: 0:30 – Tofersen (Qalsody; Biogen/Ionis) approved for SOD1-ALS 1:35 – Angela Genge, MD, FRCPC, on the approval 3:05 – The implications of targeting a root cause of ALS 5:00 – Data from the supporting VALOR study 5:55 – Genge on the context around the trial data 7:35 – Questions about access to tofersen amid accelerated approval Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com. REFERENCES 1. FDA approves treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene. News release. FDA. April 25, 2023. Accessed April 25, 2023. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-amyotrophic-lateral-sclerosis-associated-mutation-sod1-gene 2. Miller TM, Cudkowicz ME, Genge A, et al. Trial of antisense oligonucleotide tofersen for SOD1 ALS. N Engl J Med. 2022;387:1099-1110. doi:10.1056/NEJMoa2204705.

Dr Jo Rayner, Senior Research Fellow at the Australia Centre for Evidence Based Aged Care (ACEBAC), discusses her research and advocacy for the care of older people in Australia; Janine Roney, Unit Manager of the Clinical Research Unit at the Department of Infectious Diseases at Alfred Health, talks about her career in nursing and clinical research; and the team canvass emerging research into Alzheimer's disease. With presenters Nurse Epipen and Dr Kit Kat.Website: https://www.rrr.org.au/explore/programs/radiotherapyFacebook: https://www.facebook.com/RadiotherapyOnTripleR/Twitter: https://twitter.com/_radiotherapy_Instagram: https://instagram.com/radiotherapy_tripler

Our guest today is Dr. Mariela Glandt, a highly-respected endocrinologist with a wealth of experience in treating diabetes. Dr. Glandt received her education at Harvard and Columbia, and has worked at both a private clinic and Mount Sinai Hospital in New York. She is the founder and director of the Glandt Center for Diabetes Care, which uses the ketogenic diet as a primary therapeutic tool. In addition to her clinical work, Dr. Glandt has also published numerous articles in international journals, and serves as a mentor to interns at Bronx Hospital. She has also served as the director of the Clinical Research Unit for Diabetes at a medical center in Israel, and co-founded Metabolix, a non-profit organization focused on educating people about optimal metabolic health. In addition to her professional accomplishments, Dr. Glandt is also an author, having recently published "How To Eat In The Time Of Covid-19". We are thrilled to have her join us today to discuss her work and insights in the field of diabetes care.On this Episode we Discussed:Introduction of guest, Dr. Mariela Glandt, endocrinologist and founder of the Glandt Center for Diabetes CareDiscussion of the Glandt Center's use of the ketogenic diet as a primary therapeutic toolDr. Glandt's approach to baking no sugar treats for her patientsThe importance of mindset in creating lasting change in health habitsOverview of the differences between Type 1 and Type 2 diabetesDiscussion of the factors contributing to the confusion between these two types of diabetesComparison of glucose-centric and insulin-centric treatments for managing blood sugarThe natural progression of prescription medication use in diabetes managementDr. Glandt's perspective on what constitutes a healthy dietIntroduction of OWNA Health, a platform that helps doctors prescribe low-carb diets to their patientsShow Links:Link to Dr. Mariela Glandt's bio or website: Glandt.co.ilLinks to any relevant articles or research papers mentioned in the episode: The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trialLinks to any products or services mentioned in the episode: www.owna.health - a platform that helps doctors prescribe low-carb diets to their patientsDr. Mariela Glandt on LinkedInCall to action for listeners: Follow ketones and Coffee Podcast on Instagram (https://www.instagram.com/keton.esncoffee), Youtube (https://www.youtube.com/channel/UCyZia0TtezGqjGcXwXJhDoQ), and Twitter (https://twitter.com/KetonesP) for updates and new episodes.Estrella by Audiorezout is licensed under a Attribution-NonCommercial-ShareAlike 4.0 International License. Hey Ketones Krew! I have a Free Keto guide on how to calculate your Macros Correctly In this guide, You will learn the importance of each of the macronutrients and how to calculate your macros to meet your weight loss goals. There's a lot of Versions of keto out there that are notthe best way of doing keto.Download: FREE GUIDE DOWNLOADSupport the show

Our guest today is Dr. Mariela Glandt, a highly-respected endocrinologist with a wealth of experience in treating diabetes. Dr. Glandt received her education at Harvard and Columbia, and has worked at both a private clinic and Mount Sinai Hospital in New York. She is the founder and director of the Glandt Center for Diabetes Care, which uses the ketogenic diet as a primary therapeutic tool. In addition to her clinical work, Dr. Glandt has also published numerous articles in international journals, and serves as a mentor to interns at Bronx Hospital. She has also served as the director of the Clinical Research Unit for Diabetes at a medical center in Israel, and co-founded Metabolix, a non-profit organization focused on educating people about optimal metabolic health. In addition to her professional accomplishments, Dr. Glandt is also an author, having recently published "How To Eat In The Time Of Covid-19". We are thrilled to have her join us today to discuss her work and insights in the field of diabetes care.On this Episode we Discussed:Introduction of guest, Dr. Mariela Glandt, endocrinologist and founder of the Glandt Center for Diabetes CareDiscussion of the Glandt Center's use of the ketogenic diet as a primary therapeutic toolDr. Glandt's approach to baking no sugar treats for her patientsThe importance of mindset in creating lasting change in health habitsOverview of the differences between Type 1 and Type 2 diabetesDiscussion of the factors contributing to the confusion between these two types of diabetesComparison of glucose-centric and insulin-centric treatments for managing blood sugarThe natural progression of prescription medication use in diabetes managementDr. Glandt's perspective on what constitutes a healthy dietIntroduction of OWNA Health, a platform that helps doctors prescribe low-carb diets to their patientsShow Links:Link to Dr. Mariela Glandt's bio or website: Glandt.co.ilLinks to any relevant articles or research papers mentioned in the episode: The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trialLinks to any products or services mentioned in the episode: www.owna.health - a platform that helps doctors prescribe low-carb diets to their patientsDr. Mariela Glandt on LinkedInCall to action for listeners: Follow ketones and Coffee Podcast on Instagram (https://www.instagram.com/keton.esncoffee), Youtube (https://www.youtube.com/channel/UCyZia0TtezGqjGcXwXJhDoQ), and Twitter (https://twitter.com/KetonesP) for updates and new episodes.Estrella by Audiorezout is licensed under a Attribution-NonCommercial-ShareAlike 4.0 International License. Hey Ketones Krew! I have a Free Keto guide on how to calculate your Macros Correctly In this guide, You will learn the importance of each of the macronutrients and how to calculate your macros to meet your weight loss goals. There's a lot of Versions of keto out there that are notthe best way of doing keto.Download: FREE GUIDE DOWNLOADSupport the show

In part-two of this two-part series, The Good GP interviews Dr Mike Millard on internet-based cognitive behavioural therapy, or iCBT and This Way Up, the evidence-based online treatment for anxiety and depression. In part two, Mike covers the courses available on This Way Up. We also explore who can access This Way Up and how GPs can refer/prescribe. Dr Mike Millard is a Consultant Psychiatrist and Clinical Director of the Clinical Research Unit for Anxiety and Depression (CRUAD) at St Vincent's Hospital and the University of NSW. This Way Up: thiswayup.org.au/ If you have a question or would like to get in touch with The Good GP, please email wa.events@racgp.org.au

In part-one of this two-part series, The Good GP interviews Dr Mike Millard on internet-based cognitive behavioural therapy, or iCBT and This Way Up, the evidence-based online treatment for anxiety and depression. In part one, Mike explains the online treatment, its effectiveness and who is a good candidate for iCBT. Dr Mike Millard is a Consultant Psychiatrist and Clinical Director of the Clinical Research Unit for Anxiety and Depression (CRUAD) at St Vincent's Hospital and the University of NSW. This Way Up: https://thiswayup.org.au/ If you have a question or would like to get in touch with The Good GP, please email wa.events@racgp.org.au

In this episode, we talk about the ways brain injury, sustained in the context of trauma, can have longer-lasting effects than other mTBI's, and why mental health providers are in an ideal position to help clients focus on cognitive health by teaching strategies to improve functioning. Join us as Dr. Beth Twamley demystifies how the strategies used in Compensatory Cognitive Training (CCT) and Cognitive Symptom Management and Rehabilitation Therapy (CogSMART) can help to address impairments in prospective memory, attention, learning and memory, and executive functioning. We hope you check out how this recovery-oriented approach can be incorporated into your practice to empower clients to make functional gains and improve their quality of life. Dr. Twamley is a neuropsychologist and a Professor of Psychiatry at UC San Diego. Much of her work is based at the VA San Diego Healthcare System, where she is a VA Rehabilitation Research and Development Research Career Scientist and the Director of the Clinical Research Unit of the Center of Excellence for Stress and Mental Health. Dr. Twamley's research has focused on cognitive training and other interventions to improve real-world functioning for individuals with psychiatric disorders, traumatic brain injuries, and other cognitive impairments. She has developed and evaluated Compensatory Cognitive Training (CCT) and Cognitive Symptom Management and Rehabilitation Therapy (CogSMART) with funding from NIH, VA, DoD, NSF, BBRF/NARSAD, and UC San Diego grants. These treatment manuals and other clinical materials are available at no charge on her website, www.cogsmart.com. Resources mentioned in this episode: http://www.cogsmart.com/ [18:40]https://www.youtube.com/channel/UCIZPMnYv3RDIYFI7CETy7sA [18:45]https://deploymentpsych.org/COGSmart-Archive [19:50] Calls-to-action: Review webinar recording on CogSMART https://deploymentpsych.org/COGSmart-ArchiveAccess manuals on the CogSMART website: http://www.cogsmart.com/Subscribe to the Practical for Your Practice PodcastSubscribe to The Center for Deployment Psychology Monthly Email

On this episode, PrecisCa speaks with Dr. Sara Hurvitz, medical oncologist & the Director of Breast Oncology at the David Geffen School of Medicine at UCLA. Dr. Hurvitz answers the following: What are the biggest advances in breast cancer in 2021? What is your current approach to metastatic triple negative breast cancer? How do you choose between CDK4/6 inhibitors in both the curative and metastatic settings? How do you treat metastatic HER2 positive breast cancer with organ dysfunction through various lines of therapy? Did we learn any new information about T-DXD (Enhertu) in 2021? How do you envision the future development of T-DXD (Enhertu)? Sara A Hurvitz, MD, is Professor of Medicine at the University of California, Los Angeles (UCLA); co-director of the Santa Monica-UCLA Outpatient Oncology Practice; Medical Director of the Clinical Research Unit of the Jonsson Comprehensive Cancer Center at UCLA; and Director of Breast Oncology. Dr. Hurvitz received board-certification in internal medicine, hematology, and medical oncology. Dr. Hurvitz has won numerous awards over the past few years, among them the Marni Levine Memorial Breast Cancer Research Award 2008 through 2015. Visit www.precisca.com for more resources, content, and access to our entire catalogue of educational content. There you will have access to our complete library of educational videos. New episodes of the PrecisCa Oncology Podcast are released weekly. Please consider sharing our podcast, subscribing & turning on notifications to be the first to know about new releases. Together, we can raise the level of cancer care from diagnosis to recovery.

Dr. Sher Bahadur Pun is the chief of the Clinical Research Unit of Sukraraj Tropical and Infectious Disease Hospital, where he specializes in rabies, general medicine, viral and infectious disorders. Dr. Rakesh Chand is a veterinarian, physician, and researcher who also serves as the head of the Center for One Health Research and Promotion (COHRP) and the project coordinator for Making More Health. We discuss the rabies virus, tetanus, paralytic rabies, COVID origin, dying patients, and much more in this episode of On Air.

Dr. Scott H. Sicherer is the Director of the Elliot and Roslyn Jaffe Food Allergy Institute and the Elliot and Roslyn Jaffe Professor of Pediatric Allergy and Immunology. He is Chief of the Division of Allergy and Immunology in the Department of Pediatrics and Medical Director of the Clinical Research Unit, a component of Conduits-the Institutes for Translational Sciences at Icahn School of Medicine at Mount Sinai. He also authored Food Allergies: A Complete Guide For Eating When Your Life Depends on It. Dr. Sicherer shares with our listeners his incredible wealth of knowledge. Topics covered in this episode include what a reaction may look like, treatment expectations if an ER visit is necessary, oral food challenges (medically supervised feeding), the diagnostic process, causes of food allergies, and much more.  

Dr Lawrence Park is a psychiatrist. He has worked at the Experimental Therapeutics and Pathophysiology Branch at NIMH since 2014 and currently serves as medical director of the Clinical Research Unit. In this conversation, we discuss what ketamine is and what we might be able to learn from it about depression, the current state of research into ketamine as a treatment for unipolar and bipolar depression, what it's like when someone receives a ketamine infusion,  the problems with ketamine and the questions that are still outstanding. Dr Park also shares with us what it's like to work at the National Institute of Mental Health and future research goals.  Interviewed by  Dr. Anya Borissova - Give feedback here - podcast@maudsleylearning.com -  Follow us here: Twitter @maudsleypodcast Instagram @maudsleylearningpodcast

On this episode of the Nurse & Midwife Support Your Health Matters podcast we speak to Jay Court about This Way Up, a digital program to support the mental health of nurses, midwives, and students. Jay Court is the Digital Mental Health Engagement Lead for This Way Up at the Clinical Research Unit for Anxiety and Depression (CRUfAD), St Vincent's Hospital Sydney. Jay has dual backgrounds in mental health nursing and communications. Jay discusses the importance of nurses and midwives taking care of their mental health, some of the challenges and barriers to this and how online digital mental health support removes access problems. This Way Up provides evidence-based programs and resources developed and run by clinical psychologists, psychiatrists, researchers, and web technicians based at the Clinical Research Unit for Anxiety and Depression (CRUfAD) — a joint facility of St Vincent's Hospital and the University of New South Wales. The This Way Up program and resources are based on iCBT, which is internet-based cognitive behaviour therapy. Jay discusses the This Way Up programs and how a nurse or midwife experiencing a mental health concern can access them. This Way Up offers specialised resources to support you during the pandemic, including five simple steps to calm your emotions, and tips for getting through. In this episode we talk about the importance of accessing support. I hope you find this our discussion informative and useful. Look after yourself and each other Your Health Matters. Mark Aitken RN Stakeholder Engagement Manager Nurse & Midwife Support

In this episode, Chef Diego Baraona (FAACT's Recipe Developer), executive chef, culinary instructor, and former Culinary Manager of the Bionutritional Kitchen at Mount Sinai Health System in the Clinical Research Unit for Pediatric Allergy Research, sits down with FAACT to inspire us to teach our teens how to approach food allergy cooking as a beautiful adventure into food, spices, and salts instead of a restrictive view. Chef Diego reviews the importance of knife skills and equipment as he instills a love of food and eating for all. FAACT is honored to feature the top 9 allergen-free recipes created by Chef Diego in FAACT's monthly e-newsletter. To keep you in the know, here are a few links to topics mentioned in the podcast:Subscribe to FAACT's e-newsletter.Follow Chef Diego on Instagram.DiegoFood.com - Chef Diego Baraona's  Website (in development)You can find the FAACT Roundtable Podcast on Pandora, Apple Podcast, Spotify, Google Podcast, Stitcher,  iHeart Radio, Podcast Chaser, Deezer, and Listen Notes.Visit us at www.FoodAllergyAwareness.org and follow us on Facebook, Twitter, Instagram, LinkedIn, Pinterest, and YouTube. Contact us directly via Email.Sponsored by:  National Peanut BoardPlease note that today's guest was not sponsored by the National Peanut Board or compensated in any way by the sponsor to participate in this specific podcast.

In the first episode of our fifth season, our host Peter Brenders talks with Dr. Angela Genge, Executive Director of the Clinical Research Unit at the Montreal Neurological Institute, about CNS research, recruiting patients for rare disease trials and the effect of Covid-19 on clinical trials. Get on the email list at healthbiz.substack.com

Dr. Angela Genge is Director of the Clinical Research Unit at the Montreal Neurological Institute. She is a neuromuscular neurologist and leads the Amyotrophic lateral sclerosis (ALS) clinical program and multidisciplinary clinic. Dr. Genge has received numerous awards, most recently the 2018 Forbes Norris Award, the DIVA of Distinction Award, and the Governor General Diamond Jubilee Award. Ms. Leigh Stephens is a social worker and a psychosocial counsellor at the ALS Society of Quebec. She supports people living with ALS and their caregivers at every stage of the disease, from diagnosis through end of life and bereavement. Her work developing programs and services for caregivers led to her involvement in the consultation process for the development of the National Policy for Caregivers in Quebec. Dr. Genge will speak about ALS, how it progresses and what treatments are available. Ms. Stephens will provide an understanding of the types of programs and services that exist for persons living with ALS and their caregivers. We would like to thank the Lindsay Memorial Foundation for sponsoring this episode of McGill Cares. Original Air Date: December 16, 2020 McGill Cares is a weekly webcast series designed to support informal caregivers. During candid, 30-minute interviews with leading experts, Claire Webster, Alzheimer Care Consultant and Founder of the McGill Dementia Education Program, explores topics related to caring for a loved one with dementia. For more information about the McGill Dementia Education Program or to make a donation, please visit www.mcgill.ca/dementia. If you have specific topics or questions that you would like us to address during our weekly webcasts, please email us at dementia@mcgill.ca.

Takeaways from today's episode: It is okay to be vulnerable and share your struggles.Always set boundaries with each other. Don’t restrict yourself, you can find mentors for different things.Be brave and direct and ask someone to be a mentor, the worst they can say is no.Be sure to pay it forwardResourcesMentoring health researchers globally by Cole et al.  Global Health Mentoring Toolkits by Hansoti et al. Guest informationDr. Amel Ghouila is a bioinformatician coordinating a Data science for public health program in LMICs. She previously worked for the bioinformatics capacity building network H3ABionet. Amel is the Vice President for ASBCB and the founder of a non-profit dedicated to teaching young girls coding and entrepreneurship skills. Contact Amel @ AmelGhouilaDr. Palwende BOUA is a Researcher in human genetics and nutrition at the Clinical Research Unit of Nanoro (CRUN), IRSS-DRCO, Burkina Faso. He has been working on  multi-disciplinary research projects using GWAS data in population genetics studies in nutrition-related disorders and cardiometabolic diseases in African populations. Contact Palwende @romybouaAcknowledgementsEditing by Mariana Vaz, https://www.marianacpvaz.com/Research: Emmanuela OppongProducers: Emmanuela Oppong (Producer), Alice Matimba (Senior Producer), Christine Boinett (Creator and Executive producer) and Isabela Malta (Producer).Host: Alice MatimbaMedia and Marketing: Catherine HolmesMusic: https://freesound.org/s/477388/ SponsorsWellcome Genome Campus Advanced Courses and Scientific ConferencesWellcome Sanger InstituteSocial Entrepreneurship to Spur Health

As more and more clinical trials begin analyzing the novel SARS-CoV-2 virus and the efficacy and safety of potential treatment options, many of us are left wondering about how this shift in focus will affect ongoing and future clinical trials for other diseases, especially cancer. Nataya Francis, ARNP, nurse practitioner in the Clinical Research Unit at Moffitt Cancer Center, is seeing the impact on the oncology clinical trials management process firsthand.

Dr Juan Carrique-Mas from OUCRU, our Clinical Research Unit in Ho Chi Minh City, Vietnam, tell us about his research in the development of antimicrobial resistance in small-scale poultry production. Many households in Vietnam raise animals for food production, particularly chickens, using large amounts of antimicrobials with no veterinary support, and those antimicrobials find their way into the food chain. The ViParc project conducts intervention trials similar to human clinical trials, to help farmers reduce the level of antimicrobials used when raising chickens.

Professor Tran Hien, founder member of our OUCRU unit in Vietnam tells us about the development of this very successful Clinical Research Unit. Although incidence of malaria has decreased in Vietnam, the burden of infectious diseases remains high and weighs heavily on the health care system. Clinical research aims to allow investments to go further: findings in the laboratory, tested in clinical trials and then applied to the community, help improve diagnosis and management.

Dr Abhilasha Karkey from our Clinical Research Unit in Kathmandu, Nepal, tells us how research is brought to local communities in Nepal. Antimicrobial resistance is a huge burden in Nepal, particularly in hospitals where many nosocomial infections are caused by resistant pathogens. With limited resources, little infection controls and proper guidelines in place, finding out the main risk factors helps reduce infection rates within a hospital and better target vaccination campaigns.

Sir Jeremy Farrar and Nick Pearson join James Ashton to discuss taking risks, campaigning voices and making a difference in the world’s wellbeing. Sir Jeremy Farrar is director of the Wellcome Trust, the British medical charity that spends close to £1bn every year to improve global health through research and education funded by a £26bn endowment. Wellcome has spent 25 years unravelling the human genome and has also been involved in breakthroughs that track the inner workings of the brain, diagnose prostate cancer and tackle ebola outbreaks. Before joining Wellcome six years ago, Farrar was the director of Oxford University’s Clinical Research Unit in Vietnam where his research interests were infectious diseases and tropical health. Nick Pearson is chief executive of Parkrun, a sporting movement that began life as a free five-kilometre time trial in south west London 15 years ago. It’s still free but now 300,000 runners of all abilities take part in events across 21 countries every weekend. Pearson was an elite runner and has 25 years’ experience in the sports industry. He used to run Sweatshop, an independent sports retailer set up by London Marathon co-founder Chris Brasher. Find out more @leadingpod or www.leadingpod.com

In this episode, we're joined by Dr. Richard Menzies and Dr. Jonathan Campbell from the McGill Respiratory Epidemiology and Clinical Research Unit to discuss the results of their multi-center RCT comparing 4 months of rifampin to 9 months of isoniazid for the treatment of latent TB. Their findings are outlined in two papers, entitled "Four Months of Rifampin or Nine Months of Isoniazid for Latent TB in Adults" and "Safety and Side Effects of Rifampin Versus Isoniazid in Children" published in the August 2018 issue of the New England Journal of Medicine.

Difficulty sleeping is a common presenting problem in primary practice. While sleep disruption can at times be a symptom of an underlying medical or psychological disorder, poor sleep can also negatively impact overall health and wellbeing. Panel members: Prof Ron Grunstein, Professor of Sleep Medicine, Woolcock Institute of Medical Research, University of Sydney and Royal Prince Alfred Hospital; Dr Elizabeth Mason, Clinical & Research Psychologist, Clinical Research Unit for Anxiety and Depression, St Vincent's Hospital; Dr Aliza Werner-Seidler, Research Fellow & Clinical Psychologist, Black Dog Institute; Shirley Sneddon, Lived Experience Representative Facilitated by: Dr Vered Gordon, Black Dog Institute GP Consultant Recording and sound production: James Stewart, audioPost Voiceover: Cameron Banks, Black Dog Institute

The Oxford University Clinical Research Unit (OUCRU) is a large-scale clinical and public health research unit based in Vietnam. OUCRU aims to have a positive and significant impact on global health and, in particular, the prevention, diagnosis and treatment of infectious diseases. OUCRU enjoys the support of the Vietnamese government, and they work closely with the Ministry of Health Vietnam and the Department of Health of Ho Chi Minh City. OUCRU have developed strong links with more than 20 Vietnamese hospitals and research institutions including HTD, NHTD, The National Institute of Hygiene and Epidemiology (NIHE), and Hanoi Medical University. Priority is given to health issues important to the hospitals, and to Vietnam as a whole. All work is intended not only to benefit the patients seen daily at their host hospitals, but also to help improve patient care throughout Vietnam and the region.

The Oxford University Clinical Research Unit (OUCRU) is a large-scale clinical and public health research unit based in Vietnam. OUCRU aims to have a positive and significant impact on global health and, in particular, the prevention, diagnosis and treatment of infectious diseases. OUCRU enjoys the support of the Vietnamese government, and they work closely with the Ministry of Health Vietnam and the Department of Health of Ho Chi Minh City. OUCRU have developed strong links with more than 20 Vietnamese hospitals and research institutions including HTD, NHTD, The National Institute of Hygiene and Epidemiology (NIHE), and Hanoi Medical University. Priority is given to health issues important to the hospitals, and to Vietnam as a whole. All work is intended not only to benefit the patients seen daily at their host hospitals, but also to help improve patient care throughout Vietnam and the region.

Patrick M. Catalano M.D., Director of Center for Reproductive Health at MetroHealth and the Clinical Research Unit of the Case Western Reserve; Professor, Reproductive Biology MetroHealth Medical Center/Case Western Reserve University. Series: "UCSF Consortium for Obesity Assessment, Study and Treatment" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 28512]

Patrick M. Catalano M.D., Director of Center for Reproductive Health at MetroHealth and the Clinical Research Unit of the Case Western Reserve; Professor, Reproductive Biology MetroHealth Medical Center/Case Western Reserve University. Series: "UCSF Consortium for Obesity Assessment, Study and Treatment" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 28512]

Patrick M. Catalano M.D., Director of Center for Reproductive Health at MetroHealth and the Clinical Research Unit of the Case Western Reserve; Professor, Reproductive Biology MetroHealth Medical Center/Case Western Reserve University. Series: "UCSF Consortium for Obesity Assessment, Study and Treatment" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 28512]

Patrick M. Catalano M.D., Director of Center for Reproductive Health at MetroHealth and the Clinical Research Unit of the Case Western Reserve; Professor, Reproductive Biology MetroHealth Medical Center/Case Western Reserve University. Series: "UCSF Consortium for Obesity Assessment, Study and Treatment" [Health and Medicine] [Professional Medical Education] [Show ID: 28512]

Professor Paul Brunton discusses the specific uses of the Clinical and Translational Research Unit at the University, providing researchers with cutting-edge equipment to support their work.

Angela Genge is a professor of Neurology and Neurosurgery at McGill University, Medical Director of the Clinical Research Unit and Director of the ALS Clinic and Pain Clinic at the Montreal Neurological Institute and Hospital.